SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego Health Connect, the region’s nonprofit medical information exchange, has selected New York-based Ambra Health to manage its medical images.
San Diego medtech startup Clarify Medical (formerly Skylit Medical) has raised $3.6 million in a new round of funding.
Local drugmaker Amplyx Pharmaceuticals Inc. has landed a special regulatory designation that will give the company more than a decade of market exclusivity for a drug it’s developing.
Sanford Burnham Prebys Medical Discovery Institute has created a new vice president position to lead its business development strategy.
Local medical device maker DJO Global Inc. has appointed Brady Shirley as president and CEO. Shirley is replacing Mike Mogul, who told the board he would step down Nov. 14. Mogul is staying on until the end of the year, however, to help DJO and Shirley with the transition.
Serving Seniors has hired the University of California, Irvine’s development director to lead fundraising and external affairs for the San Diego-based nonprofit.
Registered nurses at Sharp HealthCare have voted to authorize a labor strike if their union representatives are unable to reach a wage agreement with the San Diego health care system.
San Diego biotech Halozyme Therapeutics Inc. said it will collaborate with Genentech, a member of the Roche Group, to evaluate how a combination of the two firms’ products affect up to eight tumor types in clinical studies next year.
SynteractHCR’s vice president for global medicine and regulatory affairs, Martine Dehlinger-Kremer, has joined the board of the think tank European Forum for Good Clinical Practice as co-chair of its Children’s Medicines Working Party.
Local dignitaries gathered Nov. 10 to break ground on a $244 million hospital tower that will expand Sharp Chula Vista Medical Center by 197,000 square feet and 138 patient rooms.
Local science technology firm Illumina Inc. has teamed up with the Mayo Clinic to further Mayo’s genetic and genomic research.
Drugmaker Acadia Pharmaceuticals Inc., which recently got FDA approval of its antipsychotic drug Nuplazid, reported a third quarter net loss of $71 million on revenue of $5.3 million. Analysts on Wall Street were expecting about $2.9 million in revenue for the quarter.
Carlsbad drugmaker Ionis Pharmaceuticals Inc.’s stock is up over 26 percent despite a slight miss on earnings reported Wednesday.
San Diego drugmaker Sorrento Therapeutics Inc. has closed its acquisition of Pennsylvania-based Scilex Pharmaceuticals.
Local biotech Tocagen Inc. has hired a new chief executive officer as it approaches commercialization of its anti-cancer therapies.